It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
Dr. Stephen Schuster of the University of Pennsylvania School of Medicine led a study testing BiovaxID, an experimental vaccine against follicular lymphoma developed by the National Cancer Institute. Rights to it are now held by Biovest International Inc. of Worcester, Mass., and some of his co-researchers have financial ties to the company.
Researchers gave 41 patients the shellfish protein and an immune booster; 76 others received those plus the vaccine. After nearly five years, the average time until the cancer worsened was 44 months in the vaccine group and 30 months in the others.
Originally posted by fbnks
Have you seen "I am Legend"?
There's a reason these movies come out (Blindless, The Happening, I am Legend) when they do. They're triggers in the brain so when things like that do happen, no one fights because they're so familiar with it.